Tag Archive for: financing

Xeltis secures nearly €50m from the European Investment Bank (EIB) and existing shareholders to advance aXess, its vascular access conduit to the market

/in

Up to €37.5m investment from the EIB, consisting of €10m upfront with optionality to further increase by an additional €27.5m €10m investment from existing shareholders including EQT Life Sciences (EQT) and Invest-NL Follows the announcement of excellent EU pivotal trial data highlighting the transformative potential of aXess in hemodialysis treatment European market approval and US […]

Read more

Novo Holdings co-leads €40m fundraising to scale MATR Foods’ production of organic plant-based meat alternatives

/in

Financing co-led by Novo Holdings and EIFO Proceeds to fund the scaling and internationalisation of MATR’s clean label plant products Includes the development of new 4,000-tonne plant, expected to be operational by 2027 Copenhagen, Denmark, 21 October 2025 – MATR Foods (MATR), the leader in next generation fermented plant-based meat alternatives, today announced the successful completion of […]

Read more

Optimum Strategic Communications to Host 17th Annual Healthcare Investor Conference

/in ,

How can companies with promising science secure the capital they need to develop drugs What does pharma need to fill their pipelines as they look to negotiate looming patent cliffs London, UK, 7 October 2025: Optimum Strategic Communications (Optimum), the specialist life sciences communications consultancy, will be hosting its 17th Annual Healthcare Investor Conference on Thursday 9 October […]

Read more

CONNECTA Therapeutics to Advance CTH120 into Phase II Pediatric Development for Fragile X Syndrome with EIC Accelerator Support

/in

CTH120 is a first-in-class neuroplasticity modulator with strong Phase I safety and tolerability data Awarded a €2.5M European Innovation Council (EIC) Accelerator grant to prepare for Phase II development in pediatric Fragile X Syndrome (FXS) patients CONNECTA leads innovation in neurodevelopmental therapies as a unique European biotech advancing a clinical-stage FXS program Barcelona, Spain – […]

Read more

AMSilk Secures EUR 52M Strategic Financing to Accelerate Commercial Growth

/in

Funding enables AMSilk to scale industrial production and meet global customer demand for biotech produced silk-based protein materials The financing round was led by existing investor ATHOS (AT Newtec), with strong participation from fellow existing investors MIG Capital and Novo Holdings The total EUR 52M includes EUR 30M in cash and EUR 22M in convertible […]

Read more